{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T20:50:24Z","timestamp":1749243024459,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T00:00:00Z","timestamp":1529452800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s12272-018-1045-z","type":"journal-article","created":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T02:17:08Z","timestamp":1529461028000},"page":"967-976","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Aspirin-inspired acetyl-donating HDACs inhibitors"],"prefix":"10.1007","volume":"41","author":[{"given":"Jiah","family":"Lim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoojin","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Hee","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chul-Ho","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sooyeun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byoungduck","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2268-8761","authenticated-orcid":false,"given":"Young Ho","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,20]]},"reference":[{"key":"1045_CR1","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.3390\/nu6104273","volume":"6","author":"SA Bassett","year":"2014","unstructured":"Bassett SA, Barnett MP (2014) The role of dietary histone deacetylases (HDACs) inhibitors in health and disease. Nutrients 6:4273\u20134301","journal-title":"Nutrients"},{"key":"1045_CR2","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nrd2133","volume":"5","author":"JE Bolden","year":"2006","unstructured":"Bolden JE, Peart MJ, Johnstone RW (2006) Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 5:769\u2013784","journal-title":"Nat Rev Drug Discov"},{"key":"1045_CR3","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s12272-017-0998-7","volume":"41","author":"P Chun","year":"2018","unstructured":"Chun P (2018) Therapeutic effects of histone deacetylase inhibitors on kidney disease. Arch Pharm Res 41:162\u2013183","journal-title":"Arch Pharm Res"},{"key":"1045_CR4","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/npp.2016.163","volume":"42","author":"M Cuadrado-Tejedor","year":"2017","unstructured":"Cuadrado-Tejedor M, Garcia-Barroso C, Sanchez-Arias JA, Rabal O, Perez-Gonzalez M, Mederos S, Ugarte A, Franco R, Segura V, Perea G, Oyarzabal J, Garcia-Osta A (2017) A first-in-class small-molecule that acts as a dual inhibitor of HDAC and PDE5 and that rescues hippocampal synaptic impairment in Alzheimer\u2019s disease mice. Neuropsychopharmacology 42:524\u2013539","journal-title":"Neuropsychopharmacology"},{"key":"1045_CR5","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/j.1600-0854.2012.01347.x","volume":"13","author":"C D\u2019ydewalle","year":"2012","unstructured":"D\u2019ydewalle C, Bogaert E, Van Den Bosch L (2012) HDAC6 at the intersection of neuroprotection and neurodegeneration. Traffic 13:771\u2013779","journal-title":"Traffic"},{"key":"1045_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1182\/blood-2006-06-025999","volume":"109","author":"M Duvic","year":"2007","unstructured":"Duvic M, Talpur R, Ni X, Zhang C, Hazarika P, Kelly C, Chiao JH, Reilly JF, Ricker JL, Richon VM, Frankel SR (2007) Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL). Blood 109:31\u201339","journal-title":"Blood"},{"key":"1045_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.gene.2005.09.010","volume":"363","author":"MA Glozak","year":"2005","unstructured":"Glozak MA, Sengupta N, Zhang X, Seto E (2005) Acetylation and deacetylation of non-histone proteins. Gene 363:15\u201323","journal-title":"Gene"},{"key":"1045_CR8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nm.3090","volume":"19","author":"SA Golden","year":"2013","unstructured":"Golden SA, Christoffel DJ, Heshmati M, Hodes GE, Magida J, Davis K, Cahill ME, Dias C, Ribeiro E, Ables JL, Kennedy PJ, Robison AJ, Gonzalez-Maeso J, Neve RL, Turecki G, Ghose S, Tamminga CA, Russo SJ (2013) Epigenetic regulation of RAC1 induces synaptic remodeling in stress disorders and depression. Nat Med 19:337\u2013344","journal-title":"Nat Med"},{"key":"1045_CR9","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1172\/JCI106011","volume":"48","author":"D Hawkins","year":"1969","unstructured":"Hawkins D, Pinckard RN, Crawford IP, Farr RS (1969) Structural changes in human serum albumin induced by ingestion of acetylsalicylic acid. J Clin Invest 48:536\u2013542","journal-title":"J Clin Invest"},{"key":"1045_CR10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0021-9258(18)54150-8","volume":"268","author":"L Hong","year":"1993","unstructured":"Hong L, Schroth GP, Matthews HR, Yau P, Bradbury EM (1993) Studies of the DNA binding properties of histone H4 amino terminus. Thermal denaturation studies reveal that acetylation markedly reduces the binding constant of the H4 \u201ctail\u201d to DNA. J Biol Chem 268:305\u2013314","journal-title":"J Biol Chem"},{"key":"1045_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejmech.2013.11.031","volume":"73","author":"M Hrast","year":"2014","unstructured":"Hrast M, Anderluh M, Knez D, Randall CP, Barreteau H, O\u2019neill AJ, Blanot D, Gobec S (2014) Design, synthesis and evaluation of second generation MurF inhibitors based on a cyanothiophene scaffold. Eur J Med Chem 73:83\u201396","journal-title":"Eur J Med Chem"},{"key":"1045_CR12","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/nrd2681","volume":"7","author":"AG Kazantsev","year":"2008","unstructured":"Kazantsev AG, Thompson LM (2008) Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nat Rev Drug Discov 7:854\u2013868","journal-title":"Nat Rev Drug Discov"},{"key":"1045_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0092-8674(93)90051-Q","volume":"72","author":"DY Lee","year":"1993","unstructured":"Lee DY, Hayes JJ, Pruss D, Wolffe AP (1993) A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell 72:73\u201384","journal-title":"Cell"},{"key":"1045_CR14","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1158\/1078-0432.CCR-14-3119","volume":"21","author":"HZ Lee","year":"2015","unstructured":"Lee HZ, Kwitkowski VE, Del Valle PL, Ricci MS, Saber H, Habtemariam BA, Bullock J, Bloomquist E, Li Shen Y, Chen XH, Brown J, Mehrotra N, Dorff S, Charlab R, Kane RC, Kaminskas E, Justice R, Farrell AT, Pazdur R (2015) FDA approval: belinostat for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma. Clin Cancer Res 21:2666\u20132670","journal-title":"Clin Cancer Res"},{"key":"1045_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1021\/ja5112964","volume":"137","author":"J Lei","year":"2015","unstructured":"Lei J, Zhou Y, Xie D, Zhang Y (2015) Mechanistic insights into a classic wonder drug\u2013aspirin. J Am Chem Soc 137:70\u201373","journal-title":"J Am Chem Soc"},{"key":"1045_CR16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.5582\/irdr.2016.01024","volume":"5","author":"X Lu","year":"2016","unstructured":"Lu X, Ning Z, Li Z, Cao H, Wang X (2016) Development of chidamide for peripheral T-cell lymphoma, the first orphan drug approved in China. Intractable Rare Dis Res 5:185\u2013191","journal-title":"Intractable Rare Dis Res"},{"key":"1045_CR17","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.molonc.2012.09.004","volume":"6","author":"A Nebbioso","year":"2012","unstructured":"Nebbioso A, Carafa V, Benedetti R, Altucci L (2012) Trials with \u2018epigenetic\u2019 drugs: an update. Mol Oncol 6:657\u2013682","journal-title":"Mol Oncol"},{"key":"1045_CR18","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuro.2014.10.008","volume":"45","author":"O Omonijo","year":"2014","unstructured":"Omonijo O, Wongprayoon P, Ladenheim B, Mccoy MT, Govitrapong P, Jayanthi S, Cadet JL (2014) Differential effects of binge methamphetamine injections on the mRNA expression of histone deacetylases (HDACs) in the rat striatum. Neurotoxicology 45:178\u2013184","journal-title":"Neurotoxicology"},{"key":"1045_CR19","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.jacc.2016.05.083","volume":"68","author":"P Patrignani","year":"2016","unstructured":"Patrignani P, Patrono C (2016) Aspirin and cancer. J Am Coll Cardiol 68:967\u2013976","journal-title":"J Am Coll Cardiol"},{"key":"1045_CR20","first-page":"84","volume":"9","author":"LA Raedler","year":"2016","unstructured":"Raedler LA (2016) Farydak (Panobinostat): first HDAC inhibitor approved for patients with relapsed multiple myeloma. Am Health Drug Benefits 9:84\u201387","journal-title":"Am Health Drug Benefits"},{"key":"1045_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.molonc.2007.01.001","volume":"1","author":"S Ropero","year":"2007","unstructured":"Ropero S, Esteller M (2007) The role of histone deacetylases (HDACs) in human cancer. Mol Oncol 1:19\u201325","journal-title":"Mol Oncol"},{"key":"1045_CR22","first-page":"219","volume":"20","author":"J Sonnemann","year":"2008","unstructured":"Sonnemann J, Huls I, Sigler M, Palani CD, Le Hong TT, Volker U, Kroemer HK, Beck JF (2008) Histone deacetylase inhibitors and aspirin interact synergistically to induce cell death in ovarian cancer cells. Oncol Rep 20:219\u2013224","journal-title":"Oncol Rep"},{"key":"1045_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s13148-010-0006-2","volume":"1","author":"FP Tambaro","year":"2010","unstructured":"Tambaro FP, Dell\u2019aversana C, Carafa V, Nebbioso A, Radic B, Ferrara F, Altucci L (2010) Histone deacetylase inhibitors: clinical implications for hematological malignancies. Clin Epigenetics 1:25\u201344","journal-title":"Clin Epigenetics"},{"key":"1045_CR24","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/ja.2011.35","volume":"64","author":"KM Vandermolen","year":"2011","unstructured":"Vandermolen KM, Mcculloch W, Pearce CJ, Oberlies NH (2011) Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma. J Antibiot (Tokyo) 64:525\u2013531","journal-title":"J Antibiot (Tokyo)"},{"key":"1045_CR25","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s12272-013-0253-9","volume":"37","author":"YJ Zhang","year":"2014","unstructured":"Zhang YJ, Shen LL, Cheon HG, Xu YN, Jeong JH (2014) Synthesis and biological evaluation of glucagon-like peptide-1 receptor agonists. Arch Pharm Res 37:588\u2013599","journal-title":"Arch Pharm Res"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12272-018-1045-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-018-1045-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-018-1045-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:16:03Z","timestamp":1661472963000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12272-018-1045-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,20]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["1045"],"URL":"https:\/\/doi.org\/10.1007\/s12272-018-1045-z","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"type":"print","value":"0253-6269"},{"type":"electronic","value":"1976-3786"}],"subject":[],"published":{"date-parts":[[2018,6,20]]},"assertion":[{"value":"13 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}